𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transfer Factor Therapy in Patients with HBs Ag Positive Chronic Hepatitis

✍ Scribed by Yutaka Takahashi; Hiromi Tsuneta; Masahiko Okada; Norio Niikawa; Yukio Sakiyama; Shuzo Matsumoto; Toshio Lmai; Hiromichi Kojima; Hiroyoshi Itoh; Kazue Sasaki

Book ID
118710664
Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
50 KB
Volume
23
Category
Article
ISSN
1328-8067

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prolonged-interferon therapy reduces hep
Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C
✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Masahiro Kobayashi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 129 KB

## Abstract The aim of this study was to elucidate the reduction of hepatocarcinogenesis by prolonged interferon (IFN) monotherapy in aged chronic hepatitis C patients. Inclusion criteria were biopsy‐proven chronic hepatitis or liver cirrhosis, 60 years and over, elevated serum aminotransferase and

Transfer factor therapy in patients with
Transfer factor therapy in patients with cancer
✍ R. Mark Vetto; Denis R. Burger; James E. Nolte; Arthur A. Vandenbark; Harvey W. πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 712 KB

The objective of this study was to utilize transfer factor to stimulate cell-mediated immunity to specific tumor antigens in cancer patients. Thirty-five selected patients with advanced recurrent cancer, who were not suitable for further conventional therapy, were treated with transfer factor. Trans